Eman Abu‐Gharbieh

44.4k total citations · 1 hit paper
90 papers, 1.2k citations indexed

About

Eman Abu‐Gharbieh is a scholar working on Molecular Biology, Geriatrics and Gerontology and Infectious Diseases. According to data from OpenAlex, Eman Abu‐Gharbieh has authored 90 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 15 papers in Geriatrics and Gerontology and 12 papers in Infectious Diseases. Recurrent topics in Eman Abu‐Gharbieh's work include Pharmaceutical Practices and Patient Outcomes (13 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Natural product bioactivities and synthesis (6 papers). Eman Abu‐Gharbieh is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (13 papers), Metabolomics and Mass Spectrometry Studies (7 papers) and Natural product bioactivities and synthesis (6 papers). Eman Abu‐Gharbieh collaborates with scholars based in United Arab Emirates, Jordan and Egypt. Eman Abu‐Gharbieh's co-authors include Naglaa Gamil Shehab, Yasser Bustanji, Bazigha K. Abdul Rasool, Waseem El‐Huneidi, Mohamed A. Saleh, Jalal Taneera, Linda Tahaineh, Mayyada Wazaify, Abla Albsoul‐Younes and Saeed Khan and has published in prestigious journals such as PLoS ONE, Scientific Reports and The FASEB Journal.

In The Last Decade

Eman Abu‐Gharbieh

85 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation

2024 54 citations Shereen M. Aleidi, Jalal Taneera et al. Pharmaceuticals profile →

Peers

Eman Abu‐Gharbieh

EPIDE

PHARM

Abdulrhman Alsayari Saudi Arabia

Muhammad Shahid Iqbal Saudi Arabia

Patrícia Moriel Brazil

Atta Abbas Naqvi Saudi Arabia

Nilesh Patel United Kingdom

Isabel Vitória Figueiredo Portugal

Mohammed A. Hussein Egypt

Fawzy Elbarbry United States

Muhammad Fawad Rasool Pakistan

Inayat Ur Rehman Pakistan

Abdulrhman Alsayari Saudi Arabia

Eman Abu‐Gharbieh

401 ×1.4

184 ×1.1

128 ×0.8

52 ×0.4

EPIDE

131 ×1.2

PHARM

Citations per year, relative to Eman Abu‐Gharbieh Eman Abu‐Gharbieh (= 1×) peers Abdulrhman Alsayari

Countries citing papers authored by Eman Abu‐Gharbieh

Since Specialization

Citations

This map shows the geographic impact of Eman Abu‐Gharbieh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eman Abu‐Gharbieh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eman Abu‐Gharbieh more than expected).

Fields of papers citing papers by Eman Abu‐Gharbieh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eman Abu‐Gharbieh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eman Abu‐Gharbieh. The network helps show where Eman Abu‐Gharbieh may publish in the future.

Co-authorship network of co-authors of Eman Abu‐Gharbieh

This figure shows the co-authorship network connecting the top 25 collaborators of Eman Abu‐Gharbieh. A scholar is included among the top collaborators of Eman Abu‐Gharbieh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eman Abu‐Gharbieh. Eman Abu‐Gharbieh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alqudah, Mohammad A. Y., Mahmoud Mohammad Yaseen, Karem H. Alzoubi, et al.. (2025). Metabolomic Analysis, Antiproliferative, Anti-Migratory, and Anti-Invasive Potential of Amlodipine in Lung Cancer Cells. Drug Design Development and Therapy. Volume 19. 1215–1229. 1 indexed citations

Taneera, Jalal, Ahmad Y. Abuhelwa, Karem H. Alzoubi, et al.. (2024). Exploring the Anticancer Effect of Artemisia herba‐alba on Colorectal Cancer: Insights From Eight Colorectal Cancer Cell Lines. Food Science & Nutrition. 13(1). e4715–e4715. 3 indexed citations

Tarazi, Hamadeh, Ahmed M. Almehdi, Waseem El‐Huneidi, et al.. (2024). Metabolomics and Proteomics in Prostate Cancer Research: Overview, Analytical Techniques, Data Analysis, and Recent Clinical Applications. International Journal of Molecular Sciences. 25(10). 5071–5071. 8 indexed citations

Taneera, Jalal, Anila Khalique, Abdul Khader Mohammed, et al.. (2024). Investigating the Impact of IL6 on Insulin Secretion: Evidence from INS-1 Cells, Human Pancreatic Islets, and Serum Analysis. Cells. 13(8). 685–685. 1 indexed citations

Taneera, Jalal, Waseem El‐Huneidi, Eman Abu‐Gharbieh, et al.. (2024). Unlocking the Therapeutic Potential of BCL-2 Associated Protein Family: Exploring BCL-2 Inhibitors in Cancer Therapy. Biomolecules & Therapeutics. 32(3). 267–280. 12 indexed citations

Basheti, Iman A., et al.. (2024). Knowledge Gap or Prepared Force? Exploring United Arab Emirates Pharmacy Students and Pharmacists’ Monkeypox Readiness. Healthcare. 12(22). 2295–2295.

Alzubaidi, Hamzah, Lisa W. Goldstone, Basema Saddik, et al.. (2024). A roadmap beyond dispensing for educating and training community pharmacists on key mental health competencies: A mixed-methods national study. Research in Social and Administrative Pharmacy. 20(6). 134–145. 1 indexed citations

Aleidi, Shereen M., Jalal Taneera, Eman Abu‐Gharbieh, et al.. (2024). Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation. Pharmaceuticals. 17(2). 195–195. 54 indexed citations breakdown →

Bustanji, Yasser, Moyad Shahwan, Karem H. Alzoubi, et al.. (2023). Exploring the Potential of Rosemary Derived Compounds (Rosmarinic and Carnosic Acids) as Cancer Therapeutics: Current Knowledge and Future Perspectives. Biomolecules & Therapeutics. 32(1). 38–55. 10 indexed citations

10.

El‐Huneidi, Waseem, Shabana Anjum, Abdul Khader Mohammed, et al.. (2023). Rosemarinic acid protects β-cell from STZ-induced cell damage via modulating NF-κβ pathway. Heliyon. 9(9). e19234–e19234. 5 indexed citations

11.

Bustanji, Yasser, Waseem El‐Huneidi, Mohammad H. Semreen, et al.. (2023). Analysis and mapping of global scientific research on human monkeypox over the past 20 years. Veterinary World. 693–703. 6 indexed citations

12.

Bajbouj, Khuloud, Naglaa Gamil Shehab, Saryia Adra, et al.. (2023). Potential anticancer properties of calotropis procera: An investigation on breast and colon cancer cells. Heliyon. 9(6). e16706–e16706. 9 indexed citations

13.

El‐Huneidi, Waseem, Yasser Bustanji, Eman Abu‐Gharbieh, et al.. (2023). Evaluation of Two Simultaneous Metabolomic and Proteomic Extraction Protocols Assessed by Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry. International Journal of Molecular Sciences. 24(2). 1354–1354. 10 indexed citations

14.

El‐Huneidi, Waseem, Yasser Bustanji, Eman Abu‐Gharbieh, et al.. (2023). Skin Cancer Metabolic Profile Assessed by Different Analytical Platforms. International Journal of Molecular Sciences. 24(2). 1604–1604. 11 indexed citations

15.

El‐Huneidi, Waseem, Yasser Bustanji, Eman Abu‐Gharbieh, et al.. (2022). Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research. International Journal of Molecular Sciences. 24(1). 348–348. 13 indexed citations

16.

Alzubaidi, Hamzah, Catarina Samorinha, Basema Saddik, et al.. (2021). A mixed-methods study to assess COVID-19 vaccination acceptability among university students in the United Arab Emirates. Human Vaccines & Immunotherapeutics. 17(11). 4074–4082. 19 indexed citations

17.

Saber-Ayad, Maha, Eman Abu‐Gharbieh, Rifat Hamoudi, et al.. (2021). Current Status of Baricitinib as a Repurposed Therapy for COVID-19. Pharmaceuticals. 14(7). 680–680. 30 indexed citations

18.

Abu‐Gharbieh, Eman, et al.. (2018). Impact of Qualification Framework in United Arab Emirates: A case study of Dubai Pharmacy College undergraduate curriculum. Tropical Journal of Pharmaceutical Research. 17(4). 701–701. 2 indexed citations

19.

Issa, Ala, et al.. (2012). In Vivo Acute Toxicity Study of Thyme – Primulae Syrup. Jordan Journal of Pharmaceutical Sciences. 4(3). 1 indexed citations

20.

Abu‐Gharbieh, Eman, et al.. (2010). In vitro effects of Micromeria fruticosa on human leukocyte myeloperoxidase activity.. Journal of Pharmacy Research. 3(10). 2492–2493. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact